vs

Side-by-side financial comparison of APOGEE ENTERPRISES, INC. (APOG) and LivaNova PLC (LIVN). Click either name above to swap in a different company.

LivaNova PLC is the larger business by last-quarter revenue ($360.9M vs $351.4M, roughly 1.0× APOGEE ENTERPRISES, INC.). LivaNova PLC runs the higher net margin — 8.6% vs 4.7%, a 3.8% gap on every dollar of revenue. On growth, LivaNova PLC posted the faster year-over-year revenue change (12.1% vs 1.6%). Over the past eight quarters, LivaNova PLC's revenue compounded faster (10.6% CAGR vs 2.9%).

Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.

LivaNova, plc is an American medical device manufacturer based in the UK. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN".

APOG vs LIVN — Head-to-Head

Bigger by revenue
LIVN
LIVN
1.0× larger
LIVN
$360.9M
$351.4M
APOG
Growing faster (revenue YoY)
LIVN
LIVN
+10.5% gap
LIVN
12.1%
1.6%
APOG
Higher net margin
LIVN
LIVN
3.8% more per $
LIVN
8.6%
4.7%
APOG
Faster 2-yr revenue CAGR
LIVN
LIVN
Annualised
LIVN
10.6%
2.9%
APOG

Income Statement — Q4 FY2026 vs Q4 FY2025

Metric
APOG
APOG
LIVN
LIVN
Revenue
$351.4M
$360.9M
Net Profit
$16.6M
$30.9M
Gross Margin
22.4%
65.2%
Operating Margin
7.3%
11.8%
Net Margin
4.7%
8.6%
Revenue YoY
1.6%
12.1%
Net Profit YoY
568.8%
-44.7%
EPS (diluted)
$0.78
$0.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APOG
APOG
LIVN
LIVN
Q1 26
$351.4M
Q4 25
$348.6M
$360.9M
Q3 25
$358.2M
$357.8M
Q2 25
$346.6M
$352.5M
Q1 25
$345.7M
$316.9M
Q4 24
$341.3M
$321.8M
Q3 24
$342.4M
$318.1M
Q2 24
$331.5M
$318.6M
Net Profit
APOG
APOG
LIVN
LIVN
Q1 26
$16.6M
Q4 25
$16.5M
$30.9M
Q3 25
$23.6M
$26.8M
Q2 25
$-2.7M
$27.2M
Q1 25
$2.5M
$-327.3M
Q4 24
$21.0M
$55.9M
Q3 24
$30.6M
$33.0M
Q2 24
$31.0M
$16.3M
Gross Margin
APOG
APOG
LIVN
LIVN
Q1 26
22.4%
Q4 25
23.8%
65.2%
Q3 25
23.1%
68.4%
Q2 25
21.7%
67.8%
Q1 25
21.6%
69.7%
Q4 24
26.1%
68.2%
Q3 24
28.4%
70.8%
Q2 24
29.8%
68.7%
Operating Margin
APOG
APOG
LIVN
LIVN
Q1 26
7.3%
Q4 25
7.1%
11.8%
Q3 25
7.5%
15.1%
Q2 25
2.0%
15.4%
Q1 25
1.8%
15.3%
Q4 24
8.4%
11.5%
Q3 24
12.3%
11.2%
Q2 24
12.5%
12.6%
Net Margin
APOG
APOG
LIVN
LIVN
Q1 26
4.7%
Q4 25
4.7%
8.6%
Q3 25
6.6%
7.5%
Q2 25
-0.8%
7.7%
Q1 25
0.7%
-103.3%
Q4 24
6.1%
17.4%
Q3 24
8.9%
10.4%
Q2 24
9.4%
5.1%
EPS (diluted)
APOG
APOG
LIVN
LIVN
Q1 26
$0.78
Q4 25
$0.77
$0.57
Q3 25
$1.10
$0.49
Q2 25
$-0.13
$0.50
Q1 25
$0.12
$-6.01
Q4 24
$0.96
$1.04
Q3 24
$1.40
$0.60
Q2 24
$1.41
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APOG
APOG
LIVN
LIVN
Cash + ST InvestmentsLiquidity on hand
$39.5M
$635.6M
Total DebtLower is stronger
$232.3M
$376.1M
Stockholders' EquityBook value
$511.8M
$1.2B
Total Assets
$1.1B
$2.6B
Debt / EquityLower = less leverage
0.45×
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APOG
APOG
LIVN
LIVN
Q1 26
$39.5M
Q4 25
$41.3M
$635.6M
Q3 25
$39.5M
$646.1M
Q2 25
$32.8M
$593.6M
Q1 25
$41.4M
$738.4M
Q4 24
$43.9M
$428.9M
Q3 24
$51.0M
$346.4M
Q2 24
$30.4M
$329.2M
Total Debt
APOG
APOG
LIVN
LIVN
Q1 26
$232.3M
Q4 25
$376.1M
Q3 25
$434.5M
Q2 25
$430.6M
Q1 25
$285.0M
$628.2M
Q4 24
$627.0M
Q3 24
$625.5M
Q2 24
$624.5M
Stockholders' Equity
APOG
APOG
LIVN
LIVN
Q1 26
$511.8M
Q4 25
$512.3M
$1.2B
Q3 25
$500.2M
$1.2B
Q2 25
$481.8M
$1.1B
Q1 25
$487.9M
$1.0B
Q4 24
$522.1M
$1.3B
Q3 24
$506.4M
$1.3B
Q2 24
$480.0M
$1.2B
Total Assets
APOG
APOG
LIVN
LIVN
Q1 26
$1.1B
Q4 25
$1.1B
$2.6B
Q3 25
$1.2B
$2.6B
Q2 25
$1.2B
$2.5B
Q1 25
$1.2B
$2.6B
Q4 24
$1.2B
$2.5B
Q3 24
$917.1M
$2.5B
Q2 24
$889.0M
$2.5B
Debt / Equity
APOG
APOG
LIVN
LIVN
Q1 26
0.45×
Q4 25
0.31×
Q3 25
0.38×
Q2 25
0.38×
Q1 25
0.58×
0.61×
Q4 24
0.47×
Q3 24
0.48×
Q2 24
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APOG
APOG
LIVN
LIVN
Operating Cash FlowLast quarter
$122.5M
$82.4M
Free Cash FlowOCF − Capex
$50.2M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
7.8%
8.9%
Cash ConversionOCF / Net Profit
7.37×
2.67×
TTM Free Cash FlowTrailing 4 quarters
$173.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APOG
APOG
LIVN
LIVN
Q1 26
$122.5M
Q4 25
$29.3M
$82.4M
Q3 25
$57.1M
$85.1M
Q2 25
$-19.8M
$62.9M
Q1 25
$30.0M
$24.0M
Q4 24
$31.0M
$78.7M
Q3 24
$58.7M
$51.0M
Q2 24
$5.5M
$43.4M
Free Cash Flow
APOG
APOG
LIVN
LIVN
Q1 26
Q4 25
$22.9M
$50.2M
Q3 25
$52.4M
$62.2M
Q2 25
$-26.9M
$47.8M
Q1 25
$19.1M
$13.2M
Q4 24
$22.0M
$68.3M
Q3 24
$50.2M
$32.8M
Q2 24
$-1.8M
$31.2M
FCF Margin
APOG
APOG
LIVN
LIVN
Q1 26
Q4 25
6.6%
13.9%
Q3 25
14.6%
17.4%
Q2 25
-7.8%
13.6%
Q1 25
5.5%
4.2%
Q4 24
6.4%
21.2%
Q3 24
14.7%
10.3%
Q2 24
-0.5%
9.8%
Capex Intensity
APOG
APOG
LIVN
LIVN
Q1 26
7.8%
Q4 25
1.9%
8.9%
Q3 25
1.3%
6.4%
Q2 25
2.1%
4.3%
Q1 25
3.2%
3.4%
Q4 24
2.6%
3.2%
Q3 24
2.5%
5.7%
Q2 24
2.2%
3.8%
Cash Conversion
APOG
APOG
LIVN
LIVN
Q1 26
7.37×
Q4 25
1.77×
2.67×
Q3 25
2.41×
3.18×
Q2 25
2.32×
Q1 25
12.08×
Q4 24
1.48×
1.41×
Q3 24
1.92×
1.55×
Q2 24
0.18×
2.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APOG
APOG

Architectural Services$127.1M36%
Architectural Metals$110.0M31%
Architectural Glass$67.4M19%
Performance Surfaces$54.3M15%

LIVN
LIVN

Other$169.4M47%
Neuromodulation Segment$119.7M33%
Cardiopulmonary Segment$71.8M20%

Related Comparisons